Oracle leader claims Cerner doesn't compete with Epic

LISA LAKE/GETTY IMAGES FOR GEISINGER SYMPOSIUM

It may surprise you to know that after acquiring electronic health record vendor Cerner for $28 billion, Oracle no longer views Epic, its main rival on EHR tech, as a competitor. Oracle Health chair David Feinberg recently caught up with my colleague Mohana Ravindranath and discussed how the company wants to ensure that its new data products, including some that use generative AI, play nicely on top of all health records, regardless of the vendor. Still, the fact remains that Epic controls about one third of the EHR market, compared to Cerner's one quarter share, according to data from Mohana's story.

Medical Devices

Over-the-counter CGM cleared by FDA

Dexcom is officially the winner of the race to bring a continuous glucose monitor to the masses for use without a prescription, my colleagues Katie Palmer and Lizzy Lawrence report. CGMs have been used for years by people with diabetes to help them manage their condition. Called Stelo, the new device is designed for people with type 2 diabetes who do not use insulin, but it may also find a market among health or fitness conscious consumers who want to keep a close watch on their blood glucose levels.

Meta propels Headspace into VR

Headspace, which has built a growing digital health business around mental health, joined forces with Meta to launch a meditation app for Quest, the social media giant's virtual reality headset. Called Headspace XR, the newly launched VR app — developed with funding from Meta — guides users through meditation and other activities meant to encourage mental well-being.

Meta funded the development of the app as part of its effort to diversify the appeal of virtual reality beyond gaming. As for Headspace, it views VR as an opportunity to reach a younger audience and study how the technology can influence mental health. For now, Headspace doesn't plan to dive deeper into the metaverse with VR therapy or coaching.

Artificial intelligence

Overjet raises $53 million to inspect your teeth with AI

A while back, my colleague Casey Ross wrote about the rise of companies developing algorithmic products that enable dentists to spot problems earlier. Well, one of the companies in that story, Overjet, just raised $53 million led by March Capital with participation from big name investors like General Catalyst and Insight Partners. The Harvard and MIT spinout has a bundle of Food and Drug Administration cleared products that aid in the diagnosis of oral disease.

More around STAT

Check out more exclusive coverage with a STAT+ subscription

Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

What we're reading

Charging patients to message their doctors mostly benefits major hospital systems, STAT
Whistleblower accuses Aledade, largest US independent primary care network, of medicare fraud, KFF News
Scientists create elephant stem cells in the lab, New York Times
Former medical device CEO who sold dummy, plastic parts convicted of fraud, STAT